Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study

Rheumatology and Therapy ◽

10.1007/s40744-021-00366-0 ◽

2021 ◽

Author(s):

Xianmin Meng ◽

Qianqian Wang ◽

Shunquan Wu ◽

Di Pu ◽

Amber Zhang ◽

...

Keyword(s):

Single Dose ◽

Phase 1 ◽

Open Label Study ◽

Label Study ◽

Healthy Chinese ◽

Download Full-text

Pharmacokinetic properties of lansoprazole (30-mg enteric-coated capsules) and its metabolites: A single-dose, open-label study in healthy Chinese male subjects

Current Therapeutic Research ◽

10.1016/j.curtheres.2009.05.002 ◽

2009 ◽

Vol 70 (3) ◽

pp. 228-239 ◽

Author(s):

Min Song ◽

Xuan Gao ◽

Tai-Jun Hang ◽

Ai-Dong Wen

Keyword(s):

Single Dose ◽

Open Label Study ◽

Label Study ◽

Pharmacokinetic Properties ◽

Healthy Chinese ◽

Enteric Coated ◽

Male Subjects ◽

Download Full-text

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study

The Journal of Clinical Pharmacology ◽

10.1002/jcph.597 ◽

2015 ◽

Vol 56 (3) ◽

pp. 330-339 ◽

Author(s):

Paulien Ravenstijn ◽

Bart Remmerie ◽

Adam Savitz ◽

Mahesh N. Samtani ◽

Isaac Nuamah ◽

...

Keyword(s):

Single Dose ◽

Phase 1 ◽

Paliperidone Palmitate ◽

Open Label Study ◽

Download Full-text

Abstract 763: A phase 1 open-label study to investigate the potential drug-drug interaction (DDI) between single-dose (SD) dacomitinib (PF-00299804; DC) and steady-state (SS) paroxetine (PX) in healthy volunteers (HVs)

10.1158/1538-7445.am2012-763 ◽

2012 ◽

Author(s):

Ana RuizαGarcia ◽

Nagdeep Giri ◽

Robert R. LaBadie ◽

Grace Ni ◽

Tanya Boutros ◽

...

Keyword(s):

Single Dose ◽

Drug Interaction ◽

Steady State ◽

Healthy Volunteers ◽

Phase 1 ◽

Potential Drug ◽

Open Label Study ◽

Label Study ◽

Drug Drug Interaction

Download Full-text

Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors

Case Medical Research ◽

10.31525/ct1-nct03843359 ◽

2000 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-20-0985 ◽

2021 ◽

pp. molcanther.0985.2020

Author(s):

Michael S. Gordon ◽

John Nemunaitis ◽

Minal Barve ◽

Zev A. Wainberg ◽

Erika P. Hamilton ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label Study ◽

Download Full-text

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Journal of Hematology & Oncology ◽

10.1186/s13045-018-0681-6 ◽

2018 ◽

Vol 11 (1) ◽

Author(s):

Wan-Hong Zhao ◽

Jie Liu ◽

Bai-Yan Wang ◽

Yin-Xia Chen ◽

Xing-Mei Cao ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Therapy ◽

Phase 1 ◽

Cell Maturation ◽

T Cell Therapy ◽

Open Label Study ◽

Label Study ◽

B Cell Maturation ◽

B Cell Maturation Antigen

Download Full-text

Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13733 ◽

2018 ◽

Vol 84 (11) ◽

pp. 2663-2672 ◽

Author(s):

Sofie Deleu ◽

Thomas N. Kakuda ◽

Kurt Spittaels ◽

Jurgen J. Vercauteren ◽

Vera Hillewaert ◽

...

Keyword(s):

Healthy Volunteers ◽

Influenza A Virus ◽

Influenza A ◽

Multiple Dose ◽

Basic Protein ◽

Phase 1 ◽

Open Label Study ◽

Label Study ◽

Multiple Dose Pharmacokinetics

Download Full-text

A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis

Journal of Women s Health ◽

10.1089/jwh.2017.6500 ◽

2018 ◽

Vol 27 (4) ◽

pp. 492-497 ◽

Author(s):

Steven E. Chavoustie ◽

Janet K. Gersten ◽

Milroy J. Samuel ◽

Jane R. Schwebke

Keyword(s):

Single Dose ◽

Bacterial Vaginosis ◽

Adolescent Girls ◽

Phase 3 ◽

Open Label Study ◽

Download Full-text

Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.800 ◽

2020 ◽

Vol 9 (8) ◽

pp. 985-994

Author(s):

Shan Jing ◽

Zhenxian Zhang ◽

Xiaowen Chen ◽

Rui Miao ◽

Catarina Nilsson ◽

...

Keyword(s):

Phase I ◽

Carboxylic Acids ◽

Omega 3 ◽

Open Label Study ◽

Label Study ◽

Single And Multiple Doses ◽

Multiple Doses ◽

Healthy Chinese ◽

Chinese Subjects

Download Full-text

ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS

Neuro-Oncology ◽

10.1093/neuonc/noy148.073 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi20-vi20

Author(s):

Daniela A Bota ◽

Santosh Kesari ◽

David Piccioni ◽

Dawit Aregawi ◽

Patrick Roth ◽

...

Keyword(s):

Malignant Glioma ◽

Phase 1 ◽

Newly Diagnosed ◽

Who Grade ◽

Open Label Study ◽

Download Full-text